XPH (XPH) Stock Price & Analysis
XPH (XPH) rose 2.10% to USD 58.29 as of June 10, 2026 at 09:14 UTC, according to Nexqual real-time market data.
XPH last closed at USD 57.09; the session ranged USD 57.11–58.31 on volume of 33,472 shares. Market capitalization is —, with a 52-week range of USD 40.26–60.73 (PCX). Source: Nexqual, June 10, 2026 at 09:14 UTC.
Key Statistics (as of June 10, 2026 at 09:14 UTC)
| Price | USD 58.29 |
|---|---|
| Change | ▲ 2.10% (up) |
| Previous Close | USD 57.09 |
| Open | USD 57.65 |
| Day Range | USD 57.11 – 58.31 |
| 52-Week Range | USD 40.26 – 60.73 |
| Volume | 33,472 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (XPH)
Nexqual's technical model rates XPH "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 09:14 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 47.69 (neutral) |
| vs SMA50 | Above (USD 57.16) |
| MACD | -0.12 (negative) |
Financial Health Score (XPH)
Nexqual rates XPH's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 09:14 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IHE | iShares U.S. Pharmaceutical ETF | USD 93.79 | ▲ 1.19% |
| PJP | Invesco Pharmaceuticals ETF | USD 112 | ▲ 1.09% |
| XHS | State Street SPDR S&P Health Ca | USD 119.84 | ▲ 2.76% |
| XHE | State Street SPDR S&P Health Ca | USD 83.11 | ▲ 2.83% |
| XES | State Street SPDR S&P Oil & Gas | USD 120.55 | ▲ 1.62% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:14 UTC. This page is informational and not investment advice.